Laidlaw Starts F-Star Therapeutics Inc. (FSTX) at Buy
Tweet
Share
E-mailGet Alerts FSTX Hot Sheet
Price: $9.70 +0.31%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Trade Now!
Join SI Premium – FREE
Laidlaw analyst Yale Jen initiates coverage on F-Star Therapeutics Inc. (NASDAQ: FSTX) with a Buy rating and a price target of $32.00.
For an analyst ratings summary and ratings history on F-Star Therapeutics Inc. click here. For more ratings news on F-Star Therapeutics Inc. click here.
Shares of F-Star Therapeutics Inc. closed at $11.59 yesterday.
You May Also Be Interested In
- UPDATE: KeyBanc Starts Denbury Inc. (DEN) at Overweight as the Only E&P with Negative Carbon Footprint
- UPDATE: CIBC Starts Gatos Silver (GATO) at Outperformer
- Roth Capital Starts Ideanomics Inc. (IDEX) at Buy, 'Portfolio Effect Lifts Traction in Commercial EVs'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
